Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,305 | 3,271 | 1,979 | 2,715 | 3,530 |
| Receivables | 387 | 164 | 89 | 31 | 90 |
| Other current assets | 9 | 8 | 5 | 9 | 30 |
| TOTAL | $3,702 | $3,443 | $2,073 | $2,755 | $3,650 |
| Non-Current Assets | |||||
| PPE Net | 710 | 817 | 931 | 1,052 | 2,030 |
| Intangibles | 178 | 178 | 178 | 178 | 0 |
| Other Non-Current Assets | 91 | 91 | 91 | 91 | 260 |
| TOTAL | $979 | $1,086 | $1,200 | $1,321 | $2,290 |
| Total Assets | $4,681 | $4,528 | $3,274 | $4,076 | $5,070 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 307 | 343 | 335 | 401 | 250 |
| Accrued Expenses | 8 | 200 | 7 | 8 | 1 |
| Other current liabilities | N/A | N/A | N/A | N/A | 10 |
| TOTAL | $332 | $560 | $360 | $426 | $270 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 107 | 122 | 132 | 93 | 170 |
| TOTAL | $109 | $127 | $142 | $106 | $170 |
| Total Liabilities | $441 | $686 | $501 | $531 | $440 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3 | 3 | 2 | N/A | N/A |
| Common Shares | 23 | 22 | 22 | 21 | 20 |
| Retained earnings | -42,854 | -42,121 | -43,101 | -42,013 | -40,890 |
| Other shareholders' equity | 0 | 0 | 0 | -17 | -10 |
| TOTAL | $4,239 | $3,842 | $2,772 | $3,544 | $4,620 |
| Total Liabilities And Equity | $4,681 | $4,529 | $3,274 | $4,076 | $5,060 |